Dr. Bloom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
210 White Building
Philadelphia, PA 19104Phone+1 215-662-2638Fax+1 215-349-5703
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1992 - 1994
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1990 - 1992
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1987 - 1990
University of the WitwatersrandClass of 1983
Certifications & Licensure
PA State Medical License 1989 - 2024
NJ State Medical License 2013 - 2019
TX State Medical License 2018 - 2019- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients Start of enrollment: 2007 Mar 01
- Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants Start of enrollment: 2019 Nov 11
Publications & Presentations
PubMed
- ACGME Accreditation for Transplant Nephrology Training: Clarifying Why This is a Step in the Right Direction.Neeraj Singh, Michelle A Josephson, Vineeta Kumar, Roy D Bloom
American Journal of Kidney Diseases. 2024-11-21 - ACGME Accreditation for Transplant Nephrology Training: Clarifying Why This is a Step in the Right Direction.Neeraj Singh, Michelle A Josephson, Vineeta Kumar, Roy D Bloom
American Journal of Kidney Diseases. 2024-11-19 - Program Evaluation of Pharmacist-Performed Medication Adherence Assessments in Candidates for Living Donor Kidney Transplant.Linh Nguyen, Abigail Forte, Gregory Malat, Xinqi Liu, Jose Rivera
Progress in Transplantation. 2024-09-01
Journal Articles
- Twelve-Month Outcomes After Transplant of Hepatitis C–infected Kidneys into Uninfected Recipients: A Single-Group TrialDavid S Goldberg, Roy D Bloom, Vishnu S Potluri, Susanna M Nazarian, Ali Naji, Emily A Blumberg, Peter L Abt, Peter P Reese, Matthew Levine, Paige Porrett, Melissa Ble..., Annals of Internal Medicine
Lectures
- Using (Cell‐Free) DNA to Incriminate Rejection as the Cause of Kidney Allograft Dysfunction: Do We Have a Verdict?American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- Using (Cell‐Free) DNA to Incriminate Rejection as the Cause of Kidney Allograft Dysfunction: Do We Have a Verdict?Roy Bloom, MD, American Journal of Transplantation
https://www.doximity.com/articles/eb68afef-d890-48c4-9b39-b139efe7ddab
UpToDate, Wolters Kluwer Health - 2012-02-09
Press Mentions
Penn Medicine-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation ResearchJanuary 4th, 2022
CareDx to Present Key AlloSure Validation Data at ATCApril 28th, 2017
AlloSure Featured in Journal of the American Society of NephrologyMarch 9th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
